ArticlePharmaceutics2023

Novel Perspectives on the Design and Development of a Long-Acting Subcutaneous Raltegravir Injection for Treatment of HIV-In Vitro and In Vivo Evaluation.

Heba S Abd-Ellah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.